LXRX
Lexicon Pharmaceuticals Inc
Price:  
1.85 
USD
Volume:  
6,894,124.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX Relative Valuation

-900.4%
Upside

As of 2024-06-24, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (14.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.85 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -900.4%.

The range of the Relative Valuation is (16.12) - (15.26) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.1x - 30.1x 30.1x
Forward P/E multiples 21.9x - 28.5x 25.2x
Fair Price (16.12) - (15.26) (14.81)
Upside -971.3% - -925.0% -900.4%
1.85 USD
Stock Price
(14.81) USD
Fair Price

LXRX Relative Valuation - Historical P/E Data

Date P/E
2024-06-24 -3.35
2024-06-21 -3.45
2024-06-20 -3.27
2024-06-18 -3.27
2024-06-17 -3.21
2024-06-14 -3.40
2024-06-13 -3.42
2024-06-12 -3.57
2024-06-11 -3.60
2024-06-10 -3.55
2024-06-07 -3.27
2024-06-06 -3.27
2024-06-05 -3.62
2024-06-04 -3.29
2024-06-03 -3.27
2024-05-31 -3.17
2024-05-30 -3.17
2024-05-29 -3.06
2024-05-28 -3.16
2024-05-24 -3.03
2024-05-23 -3.01
2024-05-22 -3.12
2024-05-21 -3.12
2024-05-20 -3.31
2024-05-17 -3.31
2024-05-16 -3.44
2024-05-15 -3.62
2024-05-14 -3.59
2024-05-13 -3.49
2024-05-10 -3.34
2024-05-09 -3.53
2024-05-08 -3.31
2024-05-07 -3.31
2024-05-06 -3.42
2024-05-03 -3.25
2024-05-02 -3.17
2024-05-01 -3.08
2024-04-30 -2.88
2024-04-29 -2.91
2024-04-26 -2.95
2024-04-25 -2.88
2024-04-24 -2.99
2024-04-23 -3.01
2024-04-22 -3.19
2024-04-19 -3.08
2024-04-18 -3.04
2024-04-17 -3.03
2024-04-16 -3.17
2024-04-15 -3.49
2024-04-12 -3.68